期刊
SEMINARS IN ARTHRITIS AND RHEUMATISM
卷 51, 期 3, 页码 593-600出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.semarthrit.2021.03.017
关键词
OMERACT; Shared decision making; Core domain set
类别
资金
- OMERACT
- Arthritis Society
- Chronic Pain Network (Canadian Institutes of Health Research (CIHR) Strategy for Patient Oriented Research (SPOR)
- Ontario Ministry of Economic Development, Job Creation and Trade
- Children's Hospital of Eastern Ontario Research Institute
- National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health [K23AR-064372, AR060231-01]
- Canada Research Chair Program
- University of Ottawa Research Chair in Knowledge Translation to Patients
- Tier 1 Canada Research Chair in Shared Decision Making and Knowledge Translation
- Oak Foundation [OCAY-13-309]
- Northern Sydney Local Health District
- La Trobe University
- Canada Research Chair
This study utilized OMERACT methodology to establish a consensus on the core domain set for rheumatology trials of shared decision making interventions, involving patients from the beginning. The endorsed domains included knowledge of options, alignment with patient values and preferences, confidence in the chosen option, satisfaction with the decision-making process, adherence to the chosen option, and potential negative consequences of SDM interventions. Participants from 28 countries provided positive feedback, with 95% endorsing the proposed core domain set.
Objective: To gain consensus on the Outcome Measures in Rheumatology (OMERACT) core domain set for rheumatology trials of shared decision making (SDM) interventions. Methods: The process followed the OMERACT Filter 2.1 methodology, and used consensus-building methods, with patients involved since the inception. After developing the draft core domain set in previous research, we conducted five steps: (i) improving the draft core domain set; (ii) developing and disseminating whiteboard videos to promote its understanding; (iii) conducting an electronic survey to gather feedback on the draft core domain set; (iv) finalizing the core domain set and developing summaries, a plenary session video and discussion boards to promote its understanding; and (v) conducting virtual workshops with voting to endorse the core domain set. Results: A total of 167 participants from 28 countries answered the survey (62% were patients/caregivers). Most participants rated domains as relevant (81%-95%) and clear (82%-93%). A total of 149 participants (n = 48 patients/caregivers, 101 clinicians/researchers) participated in virtual workshops and voted on the proposed core domain set which received endorsement by 95%. Endorsed domains are: 1-Knowledge of options, their potential benefits and harms; 2-Chosen option aligned with each patient's values and preferences; 3-Confidence in the chosen option; 4-Satisfaction with the decision-making process; 5-Adherence to the chosen option and 6-Potential negative consequences of the SDM intervention. Conclusion: We achieved consensus among an international group of stakeholders on the OMERACT core domain set for rheumatology trials of SDM interventions. Future research will develop the Core Outcome Measurement Set. Clinical significance: Prior to this study, there had been no consensus on the OMERACT core domain set for SDM interventions. The current study shows that the OMERACT core domain set achieved a high level of endorsement by key stakeholders, including patients/caregivers, clinicians and researchers. (c) 2021 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据